Carlsmed, Inc.
CARL
$9.99
-$0.87-8.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.63M | -25.74M | -25.03M | -24.54M | -24.26M |
| Total Depreciation and Amortization | 281.00K | 220.00K | 171.00K | 145.00K | 145.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.27M | 4.59M | 3.84M | 2.85M | 2.72M |
| Change in Net Operating Assets | -4.89M | -6.93M | -5.97M | -4.66M | -4.08M |
| Cash from Operations | -28.98M | -27.86M | -26.98M | -26.21M | -25.47M |
| Capital Expenditure | -642.00K | -630.00K | -523.00K | -213.00K | -180.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.84M | -684.00K | -500.00K | -155.00K | -- |
| Cash from Investing | -25.48M | -1.31M | -1.02M | -368.00K | -180.00K |
| Total Debt Issued | -- | -25.00K | -25.00K | 6.21M | 6.21M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 93.67M | 93.66M | 194.00K | 171.00K | 34.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 11.92M | 11.92M | 25.84M | 25.84M | 52.42M |
| Repurchase of Preferred Stock | -- | -33.00K | -33.00K | -165.00K | -165.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.46M | -5.41M | -2.65M | -353.00K | 0.00 |
| Cash from Financing | 100.13M | 100.11M | 23.33M | 31.70M | 58.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.67M | 70.93M | -4.68M | 5.13M | 32.85M |